Published in Women's Health Weekly, July 4th, 2002
Robert Lindsay, MD, PhD, chief of internal medicine at Helen Hayes Hospital, Professor of Clinical Medicine, Columbia University, and principal investigator of the Actonel once-a-week approval study, stated that patients and doctors always welcome effective new treatment choices, and now there is data showing that once-a-week dosing of Actonel is therapeutically equivalent to daily 5 mg dosing.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly